Clinical Trial: to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07265466) titled 'to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban' on Nov. 17.

Brief Summary: to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

Study Start Date: Nov. 17

Study Type: INTERVENTIONAL

Condition: Drug Drug Interaction (DDI)

Intervention: DRUG: JP-1366 and clopidogrel

A randomized, open label, multiple-dosing, 6-sequence, 3-period, 3-treatment, crossover design

DRUG: JP-1366 and aspirin

An open-label, multiple-dosing, fixed sequence, 3-p...